We then examined the expression levels of the corresponding mRNAs in 10 paired clinical samples, in which LNC000894, VPS9D-AS1, and CYTOR were highly expressed in cancer, while LNC000460 and FOXD2-AS1 were not evident (Fig. 9B). The gene discussed is FOXD2; the disease is cancer.